Spring Creek Capital’s Celgene Corp CELG Stock Holding History

Spring Creek Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-460,000	Closed	-$45.7M	–	29
2019 Q3	$45.7M	Buy	460,000 +218,000	+90%	+$20.7M	21.8%	1
2019 Q2	$22.4M	Buy	242,000 +182,000	+303%	+$17.3M	8.07%	6
2019 Q1	$5.66M	Buy	+60,000	New	+$5.25M	3.01%	11

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Spring Creek Capital's CELG Position: Q4 2019 in Review

Spring Creek Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 460,000 shares — an estimated $45.7M sold.

Spring Creek Capital first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $45.7M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Spring Creek Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Spring Creek Capital sold 460,000 Celgene Corp shares in Q4 2019, an estimated $45.7M.
Spring Creek Capital first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
Spring Creek Capital's Celgene Corp position peaked at $45.7M in Q3 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Spring Creek Capital's 13F filing for Q4 2019, filed 13 Feb 2020.